Gasser P
Medical Office for Psychiatry and Psychotherapy, Solothurn, Switzerland.
ArticlePsychedelics
Guiding Through Challenging Psychedelic Experiences and "Bad Trips".
ArticlePsilocybin
Implementing psychedelic-assisted therapy: History and characteristics of the Swiss limited medical use program.
ArticleMDMA
A model training curriculum for psychedelic, psycholytic, and entactogen-assisted psychotherapy.
ArticlePsilocybin
The Afterglow Inventory (AGI): Validation of a new instrument for measuring subacute effects of classic serotonergic psychedelics.
ArticlePsilocybin
Further education in psychedelic-assisted therapy - experiences from Switzerland.
ArticleMDMA
Treatment of neuropathic pain with repeated low-dose MDMA: a case report.
PreprintPsilocybin
The Afterglow Inventory (AGI) – validation of a new instrument for measuring subacute effects of classic serotonergic psychedelics
ArticleLSD
LSD-assisted therapy in patients with anxiety: open-label prospective 12-month follow-up.
ArticleLSD
Lysergic Acid Diethylamide-Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study.
ArticleMDMA
Using a MDMA- and LSD-Group Therapy Model in Clinical Practice in Switzerland and Highlighting the Treatment of Trauma-Related Disorders.
ArticlePsilocybin
Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research.
ArticleMDMA
Acute subjective effects in LSD- and MDMA-assisted psychotherapy.
ArticlePsilocybin